Knygos.lt nariams
227,49 €
-30%
Įprastai
324,99 €
Predictive Approaches in Drug Discovery and Development
Knygos.lt nariams
227,49 €
-30%
Įprastai
324,99 €
- Išsiųsime per 12–18 d.d.
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives…
/images/books/3578495/9780470170830.jpg)
- Autorius: J Andrew Williams
- Leidėjas: Wiley
- ISBN-10: 0470170832
- ISBN-13: 9780470170830
- Formatas: 16.3 x 23.6 x 2.8 cm, kieti viršeliai
- Kalba: Anglų
Predictive Approaches in Drug Discovery and Development (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Aprašymas
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.
Knygos.lt nariams
227,49 €
-30%
Įprastai
324,99 €
Išsiųsime per 12–18 d.d.
- Autorius: J Andrew Williams
- Leidėjas: Wiley
- ISBN-10: 0470170832
- ISBN-13: 9780470170830
- Formatas: 16.3 x 23.6 x 2.8 cm, kieti viršeliai
- Kalba: Anglų
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.
Atsiliepimai